-- In his latest report, Professor Lee, consulting orthopaedic and regenerative surgeon and founder of the UK's MSK Doctors clinics, outlines the safety profile and side effects of Arthrosamid knee injections, comparing it to traditional options such as hyaluronic acid (HA). The report aims to clarify the benefits and differences of each option for patients and physicians evaluating non-surgical interventions for knee osteoarthritis (OA).
Access the full report at https://mskdoctors.com/doctors/thula-chelvan/articles/arthrosamid-injections-for-knee-pain-benefits-side-effects-cost-fda-approval
Hyaluronic acid is a naturally occurring substance in the body’s synovial fluids that provides lubrication and cushioning in the joint. HA injections supplement this fluid to reduce pain, inflammation, and stiffness, with results that can last up to six months. The treatment may involve one or several injections, with studies indicating up to 75 percent of patients reporting noticeable improvement. However, around 1 to 2 percent of patients may experience an increase in pain, which is often managed with pain relief medication.
In contrast, Arthrosamid is a synthetic hydrogel composed of polyacrylamide and water designed to integrate with the synovial tissue to remain in the joint, offering long-term mechanical support and lubrication. Administered as a single-dose injection, Arthrosamid provides symptom relief for up to three to four years. Approximately 80 percent of patients report significant improvements in knee function and reduced pain and stiffness after their treatment. Common side effects include temporary swelling or a sensation of fullness.
Professor Lee notes that while both treatments are supported by clinical evidence, Arthrosamid demonstrates superior outcomes in pain and stiffness relief and joint function, as reported in a 2018 study by Bliddal et al.
“Both hydrogel injections offer important benefits in OA care,” says Lee. “But for patients seeking longer-term relief without multiple injections, Arthrosamid may offer a preferable solution.”
As awareness of the risks associated with pain relief medications grows, so too does the demand for non-surgical solutions to knee OA. In his report, Lee points to real-world applications of Arthrosamid where personal perspectives complement clinical data. An Olympic athlete who was suffering from knee OA chose to undergo Arthrosamid treatment, reporting the hydrogel not only alleviated their pain but also enabled them to continue competing at the highest level. Similarly, another patient reported remarkable improvements in daily activities and their quality of life.
Within the MSK Doctors network of musculoskeletal specialists are a number of London clinics offering hydrogel injections, helping knee OA patients regain mobility and avoid surgery.
Learn more by visiting https://mskdoctors.com.
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Release ID: 89159141